Caroline Leriche

USPTO Granted Patents = 10 (Patent Applications = 2)

CIPO Patents = 4

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 9(Granted Patents)

Location History:

Paris, FL (US) (2016)
Paris, FR (2008 - 2017)

Company Filing History:

Merck Patent Gesellschaft MIT Beschrankter Haftung

patents

2 out of 5

Fovea Pharmaceuticals

Years Active: 2008-2017

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9624159 - Aniline derivatives, their preparation and their therapeutic application (2017-04-18),

2. 9249085 - Aniline derivatives, their preparation and their therapeutic application (2016-02-02),

3. 8586577 - Diazepane acetamide derivatives as selective 11B-HSD1 inhibitors (2013-11-19),

4. 8546575 - NIP thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydroge-nase-1 (2013-10-01),

5. 8389530 - Substituted quinazoline compounds (2013-03-05),

6. 8242107 - Diazepane-acetamide derivatives as selective 11β-HSD1 inhibitors (2012-08-14),

7. 8232272 - Benzimidazoledihydrothiadiazinone derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same (2012-07-31),

8. 8183265 - 2-adamantyl-butyramide derivatives as selective 11β-HSD1 inhibitors (2012-05-22),

9. 7375130 - Antidiabetic compounds comprising benzofuran and benzothiophene derivatives (2008-05-20),

10. 7371774 - Benzofurans and benzothiophenes (2008-05-13),

Title: Caroline Leriche: Innovator in Aniline Derivatives

Introduction

Caroline Leriche is a prominent inventor based in Paris, France. She has made significant contributions to the field of chemistry, particularly in the development of aniline derivatives and their therapeutic applications. With a total of 10 patents to her name, her work has the potential to impact various medical treatments.

Latest Patents

Among her latest patents, Caroline has focused on the therapeutic applications of aniline derivatives. One of her notable inventions relates to the treatment of glaucoma, utilizing a specific formula (I) where R1a represents H, a halogen, a (C-C)alkyl, or a CN. The formula continues with R1b, R1c, R2, R3, R4, R5, R7, R8, and R9, each representing various chemical groups that contribute to the efficacy of the compounds in medical applications.

Career Highlights

Caroline has worked with reputable companies in the pharmaceutical industry, including Merck Patent GmbH and Fovea Pharmaceuticals. Her experience in these organizations has allowed her to refine her skills and contribute to innovative projects that advance medical science.

Collaborations

Throughout her career, Caroline has collaborated with esteemed colleagues such as Denis Carniato and Didier Roche. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking inventions.

Conclusion

Caroline Leriche stands out as a dedicated inventor whose work in aniline derivatives showcases her commitment to advancing therapeutic applications. Her contributions to the field are invaluable and continue to inspire future innovations.

This text is generated by artificial intelligence and may not be accurate.